Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Bone Marrow/Stem Cells: No Edge in Breast Cancer

Article Abstract:

Four clinical trials have shown that aggressive treatment with high-dose chemotherapy and bone marrow or stem cell transplants do not improve the prognosis of breast cancer. High-dose chemotherapy damages the immune system, so bone marrow or stem cell transplants are needed to restore immunity. However, survival rates in the trials were similar in women treated aggressively and women treated with standard chemotherapy. Aggressive therapy is more expensive, and these preliminary results indicate that it may not be cost-effective. Women treated with standard chemotherapy still lived longer than women in the past, indicating that standard therapy alone has improved.

Author: Stephenson, Joan
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
Care and treatment, Bone marrow, Bone marrow transplantation, Stem cells, Stem cell transplantation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Study shows mastectomy prevents breast cancer in high-risk women

Article Abstract:

Prophylactic mastectomy may reduce the risk of breast cancer in women with the BRCA genes but women should think carefully before consenting to the procedure. Prophylactic mastectomy is the removal of one or both breasts to prevent the development of breast cancer. Women with the BRCA genes have a higher risk of breast and ovarian cancer than most women. A study of 950 women who had a prophylactic mastectomy found that the procedure reduced the risk of future breast cancer by more than 90%. However, this procedure may only be necessary in high-risk women.

Author: Stephenson, Joan
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
Health aspects, Evaluation, Prevention, Gene mutations, Gene mutation, Mastectomy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Study Indicates Utility for New Breast Cancer Prognostic Marker

Article Abstract:

Breast cancer patients who have low blood levels of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 have a better prognosis than those with high levels. These proteins help the cancer cells spread to other parts of the body.

Author: Stephenson, Joan
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Prognosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Breast cancer
Similar abstracts:
  • Abstracts: Breast cancer: an overview. The surgical management of breast cancer. Adjuvant treatment for breast cancer patients
  • Abstracts: HRT or not HRT?: Hormone replacement therapy is thought to be the best way of preventing osteoporosis in postmenopausal women
  • Abstracts: Seeding the World With Stem Cells. Disease Detectives Celebrate 50 Years of Successful Sleuthing
  • Abstracts: BRCA1 testing - advances and retreats. Survival associated with treatment vs observation of localized prostate cancer in elderly men
  • Abstracts: Technology follies: the uncritical acceptance of medical innovation. Clinical Breast and Pelvic Examination Requirements for Hormonal Contraception: Current Practice vs Evidence
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.